Overview


Rising prevalence of congestive heart failure and acute renal failure is the prime factor driving the market growth. According to the data provided by the New England Journal of Medicine, 2009, acute kidney injury has over 55% of mortality rate, resulting in the usage of renal replacement therapy. Continuous renal replacement therapy (CRRT) is primarily used for treating AKI patients that are hemodynamically unstable as it offers efficient removal of solute and a better hemodynamic stability when compared to other techniques of dialysis.
According to the data provided by Baxter,2015 the number of AKI patients across the world is predicted to reach over 1.6 million by 2020 from over 790,000 cases in 2009. Furthermore, as per the annual report of NxStage, 2013, over 190,000 acute kidney failure cases are registered in the United States alone. Moreover, as per the International Society of Nephrology, over 10% of patients hospitalised in the European Union have developed AKI with a high mortality rate. Such a high risk of AKI has significantly increased the continuous renal replacement therapy market demand. However, the high cost of CRRT is predicted to impede the market growth
By Product
Dialysates
Replacement Fluids
Systems
Disposables
By Modality
Continuous Veno-Venous Hemofiltration
Continuous Veno-Venous Hemodiafiltration
Continuous Veno-Venous Hemodialysis
Slow Continuous Ultrafiltration
By Therapy
Renal Care
Non-Renal Care
By End User
Hospitals
Dialysis Centers
Others
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
The market is classified into product, modality, therapy, end user and region. The product segment is categorised into dialysates and replacement fluids, systems and disposables. The replacement fluids and dialysates is anticipated to hold the largest continuous renal replacement therapy market share and this can be attributed to the rising need of these products during the CRRT processes along with technological advancements. The modality segment is divided into continuous veno-venous hemodiafiltration, continuous veno-venous hemofiltration, slow continuous ultrafiltration and continuous veno-venous haemodialysis. The CVVH segment is predicted to lead the market during the forecasted period owing to the higher acceptance of this modality amongst healthcare service providers due to the benefits offer by CCRT modalities.
The Europe region is predicted to subjugate the market during the forecasted timeframe and this can credited to rising prevalence of AKI owing to the increasing geriatric population, high usage rate of this procedure and rising approvals for CRRT systems shall drive the market growth.
Some of the major players of the market are Baxter International Inc., Fresenius Medical Care AGCo. KGAA, Nikkiso Co. Ltd., B. Braun, Nxstage Medical Inc., Asahi Kasei Medical Co. Ltd, Bellco S.R.L., Infomed SA.
Growth prospects
SWOT analysis
Key market trends
Key data-points affecting market growth
To provide with an exhaustive analysis on the global continuous renal replacement therapy market by product, by modality, by therapy, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Continuous Renal Replacement Therapy Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Continuous Renal Replacement Therapy Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Continuous Renal Replacement Therapy Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Continuous Renal Replacement Therapy Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Dialysates
      Replacement Fluids
        2. Systems
        3. Disposables
         3.1. Hemo-Filters
         3.2. Blood Sets
         3.3. Other Disposables
  • 8.   Continuous Renal Replacement Therapy Market, By Modality Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Continuous Veno-Venous Hemofiltration
        2. Continuous Veno-Venous Hemodiafiltration
        3. Continuous Veno-Venous Hemodialysis
        4. Slow Continuous Ultrafiltration
  • 9.   Continuous Renal Replacement Therapy Market, By Therapy Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Renal Care
        2. Non-Renal Care
  • 10.   Continuous Renal Replacement Therapy Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Hospitals
        2. Dialysis Centers
        3. Others
  • 11.   North America Continuous Renal Replacement Therapy Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2022-2028
  • 12.   Latin America Continuous Renal Replacement Therapy Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2022-2028
  • 13.   Europe Continuous Renal Replacement Therapy Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2022-2028
  • 14.   Asia Pacific Continuous Renal Replacement Therapy Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
  • 15.   Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2022-2028
  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •    1. Baxter International Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
         2. Fresenius Medical Care AGCo. KGAA
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
          3. Nikkiso Co. Ltd.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
         4. B. Braun
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
         5. Nxstage Medical Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
         6. Asahi Kasei Medical Co. Ltd
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
           7. Bellco S.R.L.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Infomed SA
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11